InvestorsHub Logo
Post# of 177193
Next 10

SC8

Followers 15
Posts 5086
Boards Moderated 0
Alias Born 10/31/2019

SC8

Re: chereb19 post# 161427

Tuesday, 05/09/2023 3:43:18 PM

Tuesday, May 09, 2023 3:43:18 PM

Post# of 177193
Again, FDA review in pre-submission discussion program is a review of whatever RDGL has submitted with goal of FDA making helpful suggestions for a stronger IDE application down road. Until the IDE application is submitted, FDA is not reviewing the device for human trials.

RDGL's Twitter statement "Our (PRnT) device is currently undergoing review with the @US_FDA." is false.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News